iSpecimen and myOnsite Deploy Mobile Phlebotomy During Coronavirus Pandemic

Published on: 

Applied Clinical Trials

iSpecimen has announced a new initiative in the battle against COVID-19 and other diseases, mobile phlebotomy support that will bring at-home sample collection to patients and donors interested in advancing research. The mobile service extends iSpecimen’s ongoing mission to advance medical research by connecting researchers with patients, biospecimens, and the data they need to perform their work.

For more information, click here.